Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed (vol 38, pg 4821, 2022)

被引：0

作者：

Citrome, Leslie ^{[1
]}

Risinger, Robert ^{[2
]}

Rajachandran, Lavanya ^{[2
]}

Robison, Heather ^{[2
]}

机构：

[1] New York Med Coll, Dept Psychiat & Behav Sci, Valhalla, NY USA

[2] BioXcel Therapeut Inc, 555 Long Wharf Dr, New Haven, CT USA

来源：

ADVANCES IN THERAPY | 2023年 / 40卷 / 01期

关键词：

D O I：

10.1007/s12325-022-02350-8

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：391 / 391

页数：1

共 38 条

[31] Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Citrome, L.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2014, 68 (12) : 1429 - 1441
[32] Lisdexamfetamine for binge eating disorder in adults: a systematic review of the efficacy and safety profile for this newly approved indication what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Citrome, L.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2015, 69 (04) : 410 - 421
[33] Deutetrabenazine for tardive dyskinesia: A systematic review of the efficacy and safety profile for this newly approved novel medicationWhat is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Citrome, Leslie
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2017, 71 (11)
[34] Valbenazine for tardive dyskinesia: A systematic review of the efficacy and safety profile for this newly approved novel medication-What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Citrome, Leslie
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2017, 71 (07)
[35] Benefit–Risk of Therapies for Relapsing–Remitting Multiple Sclerosis: Testing the Number Needed to Treat to Benefit (NNTB), Number Needed to Treat to Harm (NNTH) and the Likelihood to be Helped or Harmed (LHH): A Systematic Review and Meta-Analysis
Diogo Mendes
Carlos Alves
Francisco Batel-Marques
CNS Drugs, 2016, 30 : 909 - 929
[36] Benefit-Risk of Therapies for Relapsing-Remitting Multiple Sclerosis: Testing the Number Needed to Treat to Benefit (NNTB), Number Needed to Treat to Harm (NNTH) and the Likelihood to be Helped or Harmed (LHH): A Systematic Review and Meta-Analysis
Mendes, Diogo
Alves, Carlos
Batel-Marques, Francisco
CNS DRUGS, 2016, 30 (10) : 909 - 929
[37] Numbers needed to treat or harm and likelihood of being helped versus harmed for fremanezumab in patients who had prior inadequate response to two to four classes of migraine preventive medications: A post hoc analysis
Ashina, Messoud
Mitsikostas, Dimos D.
Campos, Verena Ramirez
Barash, Steve
Ning, Xiaoping
Diener, Hans-Christoph
HEADACHE, 2023, 63 (10): : 1351 - 1358
[38] Benefit-risk appraisal of lip-split mandibular "swing" vs. transoral approaches to posterior oral/oropharyngeal carcinomas using number needed to treat, to harm, and likelihood to be helped or harmed
Pitak-Arnnop, Poramate
Witohendro, Levyn Kay
Tangmanee, Chatpong
Subbalekha, Keskanya
Sirintawat, Nattapong
Auychai, Prim
Meningaud, Jean -Paul
Neff, Andreas
SURGICAL ONCOLOGY-OXFORD, 2022, 44

← 1 2 3 4 →